Objective assessment of tumour response to therapy based on tumour growth kinetics
Open Access
- 26 July 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 105 (5), 682-686
- https://doi.org/10.1038/bjc.2011.276
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Criticism of Tumor Response Criteria Raises Trial Design QuestionsJNCI Journal of the National Cancer Institute, 2006
- Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosisJournal of Hepatology, 2005
- Repopulation of cancer cells during therapy: an important cause of treatment failureNature Reviews Cancer, 2005
- Limitations with the response evaluation criteria in solid tumors (RECIST) guidance in disseminated pediatric malignancyPediatric Blood & Cancer, 2005
- 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec®)European Journal Of Cancer, 2003
- Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response.2003
- Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging.1997
- Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomographyThe Annals of Thoracic Surgery, 1995
- The influence of volumetric tumor doubling time, DNA ploidy, and histologic grade on the survival of patients with intracranial astrocytomas.1995
- AN ALTERNATIVE MODEL FOR THE EVALUATION OF ANTI-TUMOR ACTIVITY1981